<DOC>
	<DOCNO>NCT01522950</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled study compare efficacy nebivolol atenolol improve small artery elasticity reduce cardiovascular disease risk subject early vascular disease . Approximately 75 subject borderline/elevated blood pressure impair endothelial function , measure arterial elasticity score , recruit assign treatment group use block randomization scheme . Patients randomly allocate nebivolol , atenolol placebo , follow 9 month .</brief_summary>
	<brief_title>A Study Examining Effects Nebivolol Compared Atenolol Endothelial Function</brief_title>
	<detailed_description>The Rasmussen Disease Score ( RDS ) test panel choose methodology study . The 10 parameter RDS select ability quantify early structural functional abnormality vasculature leave ventricle appear long cardiovascular disease present . The RDS test include : large small artery elasticity ( measure pulse contour analysis ) , rest blood pressure , mild treadmill exercise test , carotid IMT , leave ventricle mass , ECG , retinal vasculature evaluation , well quantification serum NT-proBNP , microalbuminuria . Quantitative result test convert categorical classification base value stratify age gender appropriate . The categorical data score follow : normal = 0 point , borderline = 1 point , abnormal = 2 point . Point value parameter sum create RDS , value range 0-20 . Scores 0-2 classified normal , 3-5 early disease , 6+ advanced disease . Previous research show RDS powerful predictor future cardiovascular event . The small artery elasticity ( C2 ) parameter particular interest responsive change NO level effective reliable predictor future hypertension cardiovascular event . Changes C2 serve primary outcome study . Similar study use anti-hypertensive lipid-lowering intervention find significant improvement C2 value . Brachial artery flow-mediated dilation ( FMD ) measurement also measure index endothelial function , although method appear less sensitive functional change relate NO bioavailability C2 . Utilizing FMD C2 allow comparison previous study take advantage large sample size examine relative sensitivity method reliably measure endothelial dysfunction . The duration intervention study 9 month minimum time adequately detect improvement leave ventricle ( LV ) mass value . LV mass measurement critical component comprehensive assessment cardiovascular health improve within temporal window result anti-hypertensive intervention .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>borderline blood pressure ( 120145/8090 mm Hg ) ; borderline abnormal small artery elasticity ( C2 ) measure pulse contour analysis ; treatmentnaive blood pressure medication include diuretic least 30 day prior baseline visit ; able walk treadmill 3 minute ; female patient reproductive potential must use approved contraceptive method appropriate ( example , intrauterine device [ IUD ] , birth control pill , barrier device 1 month last dose study drug ; voluntary write informed consent performance studyrelated procedure part normal medical care , understand consent may withdraw subject time without prejudice future medical care . history intolerance betablockers clear contraindication use ; current pharmaceutical treatment blood pressure ; know history cardiovascular disease ( myocardial infarction , coronary artery bypass graft , unstable angina , uncontrolled arrhythmia , stroke , etc . ) ; know history diabetes ; know history hepatic , renal gastrointestinal disorder ; know history illness may cause additional risk ( determine study investigator ) ; pregnant lactate woman [ used pregnancy , betablockers may cause fetal harm ] ; participation concomitant clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>hypertension</keyword>
	<keyword>prevention</keyword>
	<keyword>endothelial function</keyword>
</DOC>